“…9,29,30 The SAIF may be employed for several purposes, mainly as myocutaneous, but also as fasciocutaneous, osteocutaneous or cutaneous flap, 31 and it has been described for reconstruction of head and neck soft tissue defects of the lower, mid and upper region of the face (which may require division of the facial artery and vein). It has also been used for malar augmentation with fascia flap only, 29,32 reconstruction of defects with hair-bearing skin, 33 tongue and/or floor of mouth defects, buccal mucosa defects, palatal defects, 34 nasal reconstruction, 35 lip reconstruction, [36][37][38] cervical esophagus repair or reconstruction, [39][40][41] hemilaryngectomy defects repair, 31 reconstruction of the neopharynx after total laryngectomy, repair of pharyngocutaneous fistulas 42 and coverage of hardware used in spine surgery. 43 There is controversy in the literature about the oncological safety of the SAIF due to the relationship between the flap and lymph nodes of the Ib region, because these nodal levels might be involved even at an early stage of OSCC, 44,45 and this can increase the risk of recurrence, 44,46,47 as well as hindering a rigorous cervical level I neck dissection.…”